Article

PDF
Access to the PDF text
Advertising



Archives of cardiovascular diseases
Volume 110, n° 1
pages 51-59 (janvier 2017)
Doi : 10.1016/j.acvd.2016.08.002
Received : 24 June 2016 ;  accepted : 19 August 2016
Cardiovascular remodeling and the peripheral serotonergic system
Remodelage cardiovasculaire et système sérotoninergique périphérique
 

Figure 1




Figure 1 : 

Deleterious cardiovascular effects of 5-hydroxytryptamine (5-HT; serotonin) and serotonergic agonists. R: receptor.

EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Close
Article Outline